A new study jointly conducted by digital chronic care management tool Omada and Evidation Health found that patients using Omada’s diabetes management program reduced their A1c level and average of 0.8 over the course of the clinical research.
The study included a total of 195 participants with Type 2 diabetes who had an average baseline A1c of 8.93%. Researchers reported that those participants...
Forty-one startups have been selected to participate in the H+ Digital Health Innovation Programme which starts on 16 September 2020.
The programme is jointly organised by the InsurTech Hub Munich and the dmac/Digital Health Hub Nuremberg/Erlangen.
During the "Business Development Weeks" the main focus will be on establishing business relationships and developing their own business model.
There...
Apple and Google are refining their COVID-19 contact tracing framework to fast-track enrollment and, for Apple device owners, completely forego the need to download a separate app, representatives of the companies announced today.
Launched today on iPhones with the iOS 13.7 update, "Exposure Notifications Express" sends device owners in participating states a push notification with the option to...
OhanaHealth, a health tech job placement company, today announced its new platform OhanaConnect to connect candidates with companies.
The service works specifically to match students and recent graduates with internships and full-time jobs in the health tech industry.
“Healthcare is relevant to every person on the planet and frankly, it’s one of the most important opportunities of our lifetime,”...
Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 diabetes.
This clearance means that the tool can be marketed to children as young as 2. It can also be used for adults. The system includes an algorithm which is able to measure a patient’s glucose...
Hogwash, or a brain activity breakthrough? Friday evening came with a long-awaited look at the work of Neuralink, Elon Musk's ambitious brain-computer interface implant startup. In the streamed progress update, Musk ran down a PowerPoint overview of the technology's capabilities, which he likened to "a Fitbit in your skull." The coin-shaped implant will read and wirelessly transmit brain signals...
Connected care company Masimo has landed and expanded FDA clearance for its O3 Regional Oximeter, for both somatic applications and monitoring changes in the cerebral hemoglobin.
It specifically monitors somatic tissue oxygenation saturation, and can detect changes in a patient’s hemoglobin, oxyhemoglobin and deoxyhemoglobin.
According to the company, its tool differs from peripheral pulse...
Pear Therapeutics highlighted data today from two studies of a digital cognitive behavioral therapy that acted as the precursor for Somryst, the prescription digital therapeutic for adults with chronic insomnia that was the first to pass through the FDA's Pre-Cert pilot pathway.
The first, a randomized controlled trial of 1,149 Australian adults with insomnia and depressive symptoms, suggested...
More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo.
The study looked at the proportion of Livongo members who had high blood pressure before and during the pandemic, specifically covering the time between mid-September of 2019 and mid-August of 2020.
The data does not support a...
Following a study looking into how adults living with Type 2 diabetes use technology to self-monitor lifestyle and health behaviors, researchers from the University of Texas Health Science Center at San Antonio found that technology-assisted self-monitoring was safe and effective in generating positive health outcomes.
The researchers noted several limitations to the study, but say the findings...
